Skip to content

A Comparative Clinical Study To See The Effect Of Amalakyadi Yog Ghanvati And Capsule Macushield In The Management Of Non-Proliferative Diabetic Retinopathy.

A Comparative Clinical Study Of Amalakyadi Yog Ghanvati And Capsule Macushield In The Management Of Trutiya-Chaturtha Patalgata Doshdushti(Non-Proliferative Diabetic Retinopathy) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065830
Enrollment
60
Registered
2024-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H350- Background retinopathy and retinalvascular changes

Interventions

None listed

Sponsors

Dr Hengane Sangam Sunil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Between the Age group 30-70 yrs. 2. Both Sex (i.e. Male and Female) 3. Diabetes Mellitus Type II 4. Patient having sign and symptoms of Non-Proliferative Diabetic Retinopathy.

Exclusion criteria

Exclusion criteria: 1. Other causes of Retinopathy as Hypertension , Glaucoma. 2. Cataract 3. Proliferative Diabetic Retinopathy. 4. Uncontrolled Diabetes Mellitus.

Design outcomes

Primary

MeasureTime frame
To Assess the efficacy of Amalakyadi Yog Ghanvati in improving visual acuity of Non-Proliferative Diabetic Retinopathy patients.Timepoint: 15 days with 3 assessments(0,7,15)

Secondary

MeasureTime frame
1. To access Reduction of Cotton Wool Spots on Retina of Diabetic Retinopathy Patients. 2. To access Reduction of Dot Blot Haemorrhage in Retina of Diabetic Retinopathy Patients. Timepoint: 15 days with 3 assessments(0,7,15)

Countries

India

Contacts

Public ContactDr Hengane Sangam Sunil

Dr D Y Patil College Of Ayurved And Research Centre Pimpri Pune

vdanandkale@gmail.com9890628486

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026